Medical Cannabis Rescheduling: A Historic Step Forward, But Not the Finish Line

The federal government’s recent move to reclassify certain state-licensed medical cannabis products from Schedule I to Schedule III represents one of the most significant federal cannabis policy shifts in decades. For the first time, the federal government is formally recognizing that state-regulated medical cannabis programs have a legitimate medical framework and should not be treated […]